Protocol 2: chronic muscular back pain (intermediate) Goal: Address long-standing muscular tension, trigger points, and chronic strain patterns Peptides: BPC-157 : 500mcg twice daily for enhanced effect TB-500 : 2.5mg twice weekly during loading, then 2mg weekly Duration: 8-12 weeks for chronic conditions Why this works: Higher BPC-157 dosing addresses stubborn chronic issues
De Schryver AM, Keulemans YC, Peters HP, Akkermans LM, Smout AJ, De Vries WR, van Berge-Henegouwen GP
Heimbrger SM, Bergmann NC, Augustin R, Gasbjerg LS, Christensen MB, Knop FK
Moser also suspects that this change in taste might also affect appetite, but his research didn't find a link between those whose taste buds change and those who lost more weight on the medications
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey
The Synergistic Potential BPC-157 is widely studied in combination with other peptides, particularly TB-500, to leverage complementary mechanisms for tissue repair research